We form strategic partnerships with pharmaceutical companies to develop and commercialize leading original medicines, ensuring patients get the treatment they need.
Bringing the world’s most innovative and proven medicines to Latin America
Jul 24, 2024
M8 Pharmaceuticals, an Acino company, Signs Exclusive Agreement with LG Chem for Novel Treatments for Type 2 Diabetes and Osteoarthritis in Latin America
May 07, 2024
M8 Pharmaceuticals, an Acino company, signs an exclusive licensing agreement with Supernus for Qelbree® (Viloxazine XR) in Latin America
Apr 02, 2024
Acino announces new regional Leadership and hub to deliver on expanded presence and capabilities in LATAM following M8 acquisition Joel Barlan appointed as head of LATAM region
Mar 19, 2024
SERB Pharmaceuticals grants exclusive license to M8 Pharmaceuticals, an Acino company, to bring Voraxaze® (Glucarpidase) to cancer patients in Latin America
Portfolio
Fortified by a commitment to integrity and care for patients, M8 focuses on the following therapeutic areas.
Partnerships
At M8, we have a strong track record as a true partner in long-standing alliances with global pharmaceutical companies, supporting them in bringing their innovation from the regulatory stage through full commercialization.
